يعرض 1 - 20 نتائج من 59 نتيجة بحث عن '"хроническая ишемия нижних конечностей"', وقت الاستعلام: 0.64s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: Сборник статей

    وصف الملف: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения: материалы VII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 17-18 мая 2022 г.; Чайковский, В. В. Сравнительный анализ лечения хронической атеросклеротической ишемии нижних конечностей у лиц пожилого и старческого возраста рентгенэндоваскулярными методами / В. В. Чайковский, Н. Н. Иоскевич. // Актуальные вопросы современной медицинской науки и здравоохранения: материалы VII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 17-18 мая 2022 г. – Екатеринбург : УГМУ, 2022. – C. 3004-3009.; http://elib.usma.ru/handle/usma/10404

  2. 2
    Academic Journal

    المصدر: Сборник статей

    وصف الملف: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения: материалы VII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 17-18 мая 2022 г.; Чайковский, В. В. Результаты ангиопластики и стентирования при поражении бедренно-подколенно-берцовых артерий типа C и D по Tasc II / В. В. Чайковский, Н. Н. Иоскевич. // Актуальные вопросы современной медицинской науки и здравоохранения: материалы VII Международной научно-практической конференции молодых учёных и студентов, Екатеринбург, 17-18 мая 2022 г. – Екатеринбург : УГМУ, 2022. – C. 2994-2999.; http://elib.usma.ru/handle/usma/10402

  3. 3
    Academic Journal

    المصدر: The Siberian Journal of Clinical and Experimental Medicine; Том 37, № 1 (2022); 96-107 ; Сибирский журнал клинической и экспериментальной медицины; Том 37, № 1 (2022); 96-107 ; 2713-265X ; 2713-2927

    وصف الملف: application/pdf

    Relation: https://cardiotomsk.elpub.ru/jour/article/view/1359/690; Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G.et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J. Vasc. Surg. 2007;45(S):S5–67. DОI: 10.1016/j.jvs.2006.12.037.; Jaff M.R., White C.J., Hiatt W.R., Fowkes G.R., Dormandy J., Razavi M. et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: A supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II): The TASC steering committee. Catheter Cardiovasc. Interv. 2015;86(4):611–625. DОI: 10.1002/ccd.26122.; Национальные рекомендации по диагностике и лечению заболеваний артерий нижних конечностей. М.; 2019:110.; Aboyans V., Ricco J.B., Bartelink M.E.L., Björck M., Brodmann M., Cohnert T. et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European Society for Vascular Surgery (ESVS): Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries. Endorsed by: the European Stroke Organization (ESO)The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur. Heart J. 2018;39(9):763–816. DОI: 10.1093/eurheartj/ehx095.; Lin Y., Tang X., Fu W., Kovach R., George J.C., Guo D. Stent fractures after superficial femoral artery stenting: Risk factors and impact on patency. J. Endovasc. Ther. 2015;22(3):319–326. DОI: 10.1177/1526602815580783.; Duda S.H., Bosiers M., Lammer J., Scheinert D., Zeller T., Oliva V. et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: Long-term results from the SIROCCO trial. J. Endovasc. Ther. 2006;13(6):701–710. DОI: 10.1583/05-1704.1.; Laird J.R., Katzen B.T., Scheinert D., Lammer J., Carpenter J., Buchbinder M. et al. Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: Three-year follow-up from the RESILIENT randomized trial. J. Endovasc. Ther. 2012;19(1):1–9. DОI: 10.1583/11-3627.1.; Werner M., Paetzold A., Banning-Eichenseer U., Scheinert S., Piorkowski M., Ulrich M. et al. Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry. EuroIntervention. 2014;10(7):861–868. DОI: 10.4244/EIJV10I7A147.; Garcia L., Jaff M.R., Metzger C., Sedillo G., Pershad A., Zidar F. et al. Wire-interwoven nitinol stent outcome in the superficial femoral and proximal popliteal arteries: Twelve-month results of the SUPERB trial. Circ. Cardiovasc. Interv. 2015;8(5):e000014. DОI: 10.1161/CIRCINTERVENTIONS.113.000937.; Conte M.S., Bradbury A.W., Kolh P., White J.V., Dick F., Fitridge R. et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur. J. Vasc. Endovasc. Surg. 2019;58(1S):S1–S109.e33. DОI: 10.1016/j.ejvs.2019.05.006.; Ruzankin P.S. A fast algorithm for maximal propensity score matching. Methodol. Comput. Appl. Probab. 2020;(22):477–495. DОI: 10.1007/s11009-019-09718-4.; Okuno S., Iida O., Iida T., Yamaoka T., Kitano I., Asai M. et al. Comparison of clinical outcomes between endovascular therapy with self-expandable nitinol stent and femoral-popliteal bypass for trans-atlantic inter-society consensus II C and D femoropopliteal lesions. Ann. Vasc. Surg. 2019;57:137–143. DОI: 10.1016/j.avsg.2018.09.024.; Siracuse J.J., Giles K.A., Pomposelli F.B., Hamdan A.D., Wyers M.C., Chaikof E.L. et al. Results for primary bypass versus primary angioplasty/stent for intermittent claudication due to superficial femoral artery occlusive disease. J. Vasc. Surg. 2012;55(4):1001–1007. DОI: 10.1016/j.jvs.2011.10.128.; ihara H., Soga Y., Mii S., Okazaki J., Yamaoka T., Kamoi D. et al. Comparison of long-term outcome after endovascular therapy versus bypass surgery in claudication patients with Trans-Atlantic Inter-Society Consensus-II C and D femoropopliteal disease. Circ. J. 2014;78(2):457–464. DОI: 10.1253/circj.cj-13-1147.; Enzmann F.K., Nierlich P., Aspalter M., Hitzl W., Dabernig W., Hölzenbein T. et al. Nitinol stent versus bypass in long femoropopliteal lesions: 2-year results of a randomized controlled trial. JACC Cardiovasc. Interv. 2019;12(24):2541–2549. DОI: 10.1016/j.jcin.2019.09.006.; Lammer J., Zeller T., Hausegger K.A., Schaefer P.J., Gschwendtner M., Mueller-Huelsbeck S. et al. Sustained benefit at 2 years for covered stents versus bare-metal stents in long SFA lesions: Тhe VIASTAR trial. Cardiovasc. Intervent. Radiol. 2015;38(1):25–32. DОI: 10.1007/s00270-014-1024-9.; Reijnen M.M.P.J., van Walraven L.A., Fritschy W.M., Lensvelt M.M.A., Zeebregts C.J., Lemson M.S. et al. 1-year results of a multicenter randomized controlled trial comparing heparin-bonded endoluminal to femoropopliteal bypass. JACC Cardiovasc. Interv. 2017;10(22):2320–2331. DОI: 10.1016/j.jcin.2017.09.013.; https://cardiotomsk.elpub.ru/jour/article/view/1359

  4. 4
    Academic Journal

    المصدر: Сборник статей

    وصف الملف: application/pdf

    Relation: Актуальные вопросы современной медицинской науки и здравоохранения: Материалы VI Международной научно-практической конференции молодых учёных и студентов, посвященной году науки и технологий, (Екатеринбург, 8-9 апреля 2021): в 3-х т.; Чайковский, В. В. Результаты рентгенэндоваскулярных вмешательств у пациентов с хронической ишемией нижних конечностей атеросклеротического генеза в раннем послеоперационном периоде / В. В. Чайковский, Н. Н. Иоскевич // Актуальные вопросы современной медицинской науки и здравоохранения: материалы VI Международной научно-практической конференции молодых учёных и студентов, посвященной году науки и технологий, (Екатеринбург, 8-9 апреля 2021 г.) : в 3-х т. – Екатеринбург : УГМУ, 2021. – Т.2. – С. 1219-1223.; http://elib.usma.ru/handle/usma/6085

  5. 5
    Academic Journal
  6. 6
    Academic Journal
  7. 7
    Academic Journal

    وصف الملف: application/pdf

    Relation: Уральский медицинский журнал. 2020. № 4(187).; Рентгенхирургические эндоваскулярные методы реваскуляризации (баллонная ангиопластика со стентированием) периферических артерий у пациентов с критической ишемией нижних конечностей при сахарном диабете / С. Д. Чевгун, А. М. Туркменов, Э. М. Туркменова [и др.]. – Текст: электронный // Уральский медицинский журнал. - 2020. – № 4(187). – С. 165-172.; http://elib.usma.ru/handle/usma/18988

  8. 8
    Academic Journal
  9. 9
    Academic Journal
  10. 10
    Academic Journal

    المصدر: Meditsinskiy sovet = Medical Council; № 12 (2017); 148-153 ; Медицинский Совет; № 12 (2017); 148-153 ; 2658-5790 ; 2079-701X ; 10.21518/2079-701X-2017-12

    وصف الملف: application/pdf

    Relation: https://www.med-sovet.pro/jour/article/view/2047/2029; Fowkes FG, Rudan D, Rudan I et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet, 2013, 382(9901): 1329-40.; Go AS, Mozaffarian D, Roger VL et al. Executive summary: heart disease and stroke statistics–2014 update: a report from the American Heart Association. Circulation, 2014, 129(3): 399-410.; Cardiovascular diseases. Fact sheet#317, 2011. WHO Library Catalogung in Publication Data.; Национальные рекомендации по ведению пациентов с патологией артерий нижних конечностей. Ангиология и сосудистая хирургия (Приложение), 2013, 19(2): 1-675.; Norgen L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg, 2007, 33(Suppl 1).; Vogel TR, Dombrovskiy VY, Carson JL, et al. In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia. Journal of vascular surgery, 2011, 54(1): 109-15.; Tendera M, Aboyans V, Bartelink ML et al. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). European heart journal. 2011, 32(22): 2851-90.; Abola MT, Bhatt DL, Duval S et al. Fate of individuals with ischemic amputations in the REACH Registry: three-year cardiovascular and limb-related outcomes. Atherosclerosis, 2012, 221(2): 527-35.; Mangiafico RA, Mangiafico M. Medical treatment of critical limb ischemia: current state and future directions. Current vascular pharmacology, 2011, 9(6): 658-76.; Conte MS, Geraghty PJ, Bradbury AW et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. Journal of vascular surgery, 2009, 50(6): 1462-73.; de Donato G, Gussoni G, de Donato G et al. The ILAILL study: iloprost as adjuvant to surgery for acute ischemia of lower limbs: a randomized, placebo-controlled, double-blind study by the italian society for vascular and endovascular surgery. Annals of surgery, 2006, 244(2): 185-93.; Goodney PP, Nolan BW, Schanzer A et al. Factors associated with amputation or graft occlusion one year after lower extremity bypass in northern New England. Annals of vascular surgery, 2010, 24(1): 57-6.; Korabathina R, Weintraub AR, Price LL et al. Twenty-year analysis of trends in the incidence and in-hospital mortality for lower-extremity arterial thromboembolism. Circulation, 2013, 128(2): 115-21.; Criqui MH, Langer RD, Fronek A et al. Mortality over a period of 10 years in patients with peripheral arterial disease. The New England journal of medicine, 1992, 326(6): 381-6.; Покровский А.В. Клиническая ангиология. 2004. Т. 1: 35-36.; Покровский А.В., Ивандаев А.С. Состояние сосудистой хирургии в России в 2016 году. Ангиология и сосудистая хирургия, 2017: 5-44.; Rooke TW, Hirsch AT, Misra S et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/AHA guideline recommendations): a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiology, 2013, 61: 1555-70.; Bhatt D, Scheiman J, at all. ACCF/ACG/AHA 2008 Expert consensus Document on Reducing the Gastrointestinal Risks of Antplatelet Therapy. J Am Coll Card, 2008, 52(18): 1502-1517.; Толпыгина С.Н., Марцевич С.Ю., Хосева Е.Н. Эффективность и безопасность применения ацетилсалициловой кислоты в первичной и вторичной профилактике сердечно-сосудистых заболеваний. Рациональная фармакотерапия в кардиологии, 2012, 8(2): 205-210.; Bedenis R, Lethaby A, Maxwell H, Acosta S, Prins MH. Antiplatelet agents forpreventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev, 2015, 2: CD000535.; Anderson JL, Halperin JL, Albert NM et al. Management of patients with peripheral artery disease (compilation of 2005 and 2011 ACCF/ AHA guideline recommendations): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 2013, 127(13): 1425-43.; Berger JS, Krantz MJ, Kittelson JM et al. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA, 2009, 301(18): 1909-19.; Fowkes FG, Price JF, Stewart MC, Butcher I, Leng GC, Pell AC, Sandercock PA, Fox KA, Lowe GD, Murray GD. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a ran-domized controlled trial. JAMA, 2010, 303: 841–848.; Belch J еt al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomized placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ, 2008, 337: a1840.; Von Beckerath N, Kastrati A, Wieczorek A et al. A double-blind, randomized study on platelet aggregation in patients treated with a daily dose of 150 or 75 mg of clopidogrel for 30 days. European Heart Journal, 2007, 28: 1814-9.; Muntner P, Wildman RP, Reynolds K, Desalvo KB, Chen J, Fonseca V. Relationship between HbA1c level and peripheral arterial disease. Diabetes Care, 2005, 28(8): 1981-1987.; Bhatt DL, Fox KA, Hacke W et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. The New England journal of medicine, 2006, 354(16): 1706-17.; Wedemeyer RS, Blume H. Pharmacokinetic drug interaction profiles of proton pump inhibitors: an update. Drug safety: an international journal of medical toxicology and drug experience, 2014, 37(4): 201-11; Subhash B. New Developments in Antiplatelet Therapies for Patients with Peripheral Artery Disease. J Am Coll Cardiology, 2016. www. http: //www.acc.org.; Anand S, Yusuf S, Xie C et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. The New England Journal of Medicine, 2007, 357(3): 217-27.; Andreotti F, Testa L, Biondi-Zoccai GG et al. Aspirin plus warfarin compared to aspirin alone after acute coronary syndromes: an updated and comprehensive meta-analysis of 25,307 patients. European Heart Journal, 2006, 27(5): 519-26.; WAVE-Investigators. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials. American Heart Journal, 2006, 151(1): 1-9.; Aboyans V, Ricco J-B, Bartelink M-L, Bjo¨rck M, Brodmann M. 2017 ESC Guidelines on the Diagnosis andTreatment of Peripheral Arterial Diseases,in collaboration with the European Societyfor Vascular Surgery (ESVS). European Heart Journal, 2017, 00: 1–60.; Alonso-Coello P, Bellmunt S, McGorrian C et al. Antithrombotic therapy in peripheral artery disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians EvidenceBased Clinical Practice Guidelines. Chest, 2012, 141.; Duncan D, Wijeysundera D. Preoperative Cardiac evaluation and management of the patient undergoing major vascular surgery. International Anesthesiology Clinics, 2016, 54(2): 1-32.; IN.PACT™ Admiral™ Paclitaxel-coated PTA Balloon Catheter Instruction for Use.; Zilver PTX™ Drug Eluting Stent Instruction for Use.; https://www.med-sovet.pro/jour/article/view/2047

  11. 11
  12. 12
    Academic Journal

    المصدر: Клінічна та експериментальна патологія; Том 14 № 1 (2015) ; Клиническая и экспериментальная патология; Том 14 № 1 (2015) ; Clinical & experimental pathology; Vol. 14 No. 1 (2015) ; 1727-4338

    وصف الملف: application/pdf

  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20